MetLife Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.5M | Buy |
8,951
+61
| +0.7% | +$17.6K | 0.01% | 942 |
|
|
2025
Q4 | $2.69M | Sell |
8,890
-500
| -5% | -$156K | 0.01% | 923 |
|
|
2025
Q3 | $2.63M | Buy |
+9,390
| New | +$2.56M | 0.01% | 960 |
|
|
2025
Q2 | – | Sell |
-10,695
| Closed | -$2.6M | – | 2845 |
|
|
2025
Q1 | $2.6M | Sell |
10,695
-153
| -1% | -$46K | 0.01% | 916 |
|
|
2024
Q4 | $3.56M | Buy |
10,848
+948
| +10% | +$322K | 0.02% | 750 |
|
|
2024
Q3 | $3.31M | Buy |
9,900
+4,478
| +83% | +$1.42M | 0.02% | 765 |
|
|
2024
Q2 | $1.48M | Buy |
5,422
+529
| +11% | +$154K | 0.01% | 1134 |
|
|
2024
Q1 | $1.69M | Sell |
4,893
-182
| -4% | -$59.8K | 0.01% | 1037 |
|
|
2023
Q4 | $1.64M | Sell |
5,075
-94
| -2% | -$29.5K | 0.01% | 1034 |
|
|
2023
Q3 | $1.85M | Sell |
5,169
-243
| -4% | -$93.8K | 0.01% | 932 |
|
|
2023
Q2 | $2.05M | Sell |
5,412
-143
| -3% | -$58.2K | 0.01% | 925 |
|
|
2023
Q1 | $2.66M | Sell |
5,555
-9
| -0.2% | -$4.21K | 0.02% | 800 |
|
|
2022
Q4 | $2.34M | Sell |
5,564
-69
| -1% | -$27.9K | 0.02% | 838 |
|
|
2022
Q3 | $2.35M | Sell |
5,633
-138
| -2% | -$68.8K | 0.02% | 809 |
|
|
2022
Q2 | $2.86M | Sell |
5,771
-46
| -0.8% | -$24K | 0.02% | 745 |
|
|
2022
Q1 | $3.28M | Buy |
5,817
+1,097
| +23% | +$661K | 0.02% | 782 |
|
|
2021
Q4 | $3.57M | Sell |
4,720
-65
| -1% | -$48.6K | 0.03% | 584 |
|
|
2021
Q3 | $3.57M | Sell |
4,785
-142
| -3% | -$106K | 0.03% | 542 |
|
|
2021
Q2 | $3.17M | Sell |
4,927
-139
| -3% | -$84.6K | 0.03% | 643 |
|
|
2021
Q1 | $2.89M | Sell |
5,066
-92
| -2% | -$54.5K | 0.03% | 694 |
|
|
2020
Q4 | $3.01M | Sell |
5,158
-195
| -4% | -$111K | 0.03% | 620 |
|
|
2020
Q3 | $2.76M | Sell |
5,353
-190
| -3% | -$96.2K | 0.03% | 576 |
|
|
2020
Q2 | $2.5M | Sell |
5,543
-6,860
| -55% | -$3.03M | 0.03% | 618 |
|
|
2020
Q1 | $4.35M | Hold |
12,403
| – | – | 0.06% | 295 |
|
|
2019
Q4 | $4.59M | Sell |
12,403
-98
| -0.8% | -$34.5K | 0.05% | 394 |
|
|
2019
Q3 | $4.16M | Buy |
12,501
+632
| +5% | +$206K | 0.05% | 413 |
|
|
2019
Q2 | $3.71M | Sell |
11,869
-408
| -3% | -$122K | 0.04% | 501 |
|
|
2019
Q1 | $3.75M | Sell |
12,277
-3
| -0% | -$810 | 0.04% | 489 |
|
|
2018
Q4 | $2.85M | Buy |
12,280
+12
| +0.1% | +$3.22K | 0.03% | 571 |
|
|
2018
Q3 | $3.84M | Sell |
12,268
-462
| -4% | -$143K | 0.04% | 514 |
|
|
2018
Q2 | $3.67M | Buy |
12,730
+115
| +0.9% | +$31.8K | 0.04% | 479 |
|
|
2018
Q1 | $3.15M | Sell |
12,615
-175
| -1% | -$44.6K | 0.04% | 578 |
|
|
2017
Q4 | $3.05M | Buy |
+12,790
| New | +$3.1M | 0.03% | 629 |
|
Other funds holding BIO
VCM
VPM
AI
